SCM
Stonepine Capital Management Portfolio holdings
AUM
$114M
1-Year Est. Return
77.6%
This Fund
S&P 500
1 Year Est. Return
+77.6%
AUM
$114M
AUM Growth
-$12.7M
(-10%)
Holding
86
Top Buys
| 1 | +$13M | |
| 2 | +$5.51M | |
| 3 | +$3.52M | |
| 4 |
Curis
CRIS
|
+$3.41M |
| 5 |
Sol-Gel Technologies
SLGL
|
+$2.01M |
Top Sells
| 1 | +$3.59M | |
| 2 | +$2.47M | |
| 3 | +$2.39M | |
| 4 |
Eledon Pharmaceuticals
ELDN
|
+$2.02M |
| 5 |
Edesa Biotech
EDSA
|
+$1.97M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gossamer Bio
GOSS
$46.6M
| – | – |
-204,770
|
|
||
77
Indivior Pharmaceuticals
INDV
$3.89B
| – | – |
-100,000
|
|
||
78
Kiora Pharmaceuticals
KPRX
$12.1M
| – | – |
-131,144
|
|
||
|
KZR
79
DELISTED
Kezar Life Sciences
KZR
| – | – |
-156,179
|
|
||
80
Milestone Pharmaceuticals
MIST
$166M
| – | – |
-662,666
|
|
||
81
Ultragenyx Pharmaceutical
RARE
$2.14B
| – | – |
0
|
|
||
|
SMLR
82
DELISTED
Semler Scientific
SMLR
| – | – |
-50,000
|
|
||
|
TERN
83
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
0
|
|
||
84
Tenaya Therapeutics
TNYA
$176M
| – | – |
-352,001
|
|
||
85
State Street SPDR S&P Biotech ETF
XBI
$7.8B
| – | – |
0
|
|
||
|
SPRB
86
Spruce Biosciences
SPRB
$135M
| – | – |
-19,742
|
|